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Before 2001, residential exposure to organo-
phosphate pesticides, including chlorpyri-
fos and diazinon, was common, even in an 
urban setting. Insecticides are used in mul-
tiunit, inner-city dwellings to control insect 
and rodent infestations within apartments, in 
common spaces, and around building exte-
riors. Despite the voluntary cancellation of 
residential use registrations of chlorpyrifos 
and diazinon in 2001 and 2004, respectively, 
between June 2005 and March 2006, 78% of 
randomly selected nationally representative 
U.S. homes had measurable levels of chlorpy-
rifos, and 35% had measurable levels of diazi-
non, suggesting ongoing residential exposure 
(Stout et al. 2009). Additionally, exposure to 
organophosphate pesticides or their residues 
may occur via consumption of conventionally 
grown fruits and vegetables (Lu et al. 2008).
Neurodevelopmental consequences of 
human exposure to organophosphate pes-
ticides have been demonstrated in urban 
(Bouchard et al. 2010; Engel et al. 2007; 
Rauh et al. 2006), rural (Eskenazi et al. 2007, 
2010; Young et al. 2005), and occupational 
settings (Handal et al. 2008; Roldan-Tapia 
et al. 2006), some of which specifically 
involve prenatal exposure (Engel et al. 2007; 
Eskenazi et al. 2007, 2010; Marks et al. 2010; 
Rauh et al. 2006; Young et al. 2005). We 
have previously reported that prenatal pes-
ticide exposure was associated with smaller 
head circumference (Berkowitz et al. 2004) 
and more abnormal primitive reflexes (Engel 
et al. 2007), particularly among children of 
mothers with low paraoxonase 1 (PON1) 
activity. PON1 is a key enzyme in the metab-
olism of organophosphate pesticides (Costa 
et al. 1999) and has been shown to be a bio-
marker of susceptibility to the toxic effects of 
organophophate pesticides, both in animals 
(Costa et al. 2003) and in humans (Engel 
et al. 2007; Eskenazi et al. 2010; Lee et al. 
2003; Nielsen et al. 2010).
We undertook an investigation of the 
impact of prenatal organophosphate metabo-
lite biomarker levels in relation to cognitive 
development at multiple times in childhood, 
while considering the modifying influence 
of maternal and child PON1 genotype and 
enzymatic activity.
Methods
The Mount Sinai Children’s Environmental 
Health Cohort study is a prospective multieth-
nic cohort that enrolled primiparous women 
who presented for prenatal care with single-
ton pregnancies at the Mount Sinai prenatal 
clinic and two private practices and were sub-
sequently delivered at Mount Sinai Hospital 
between May 1998 and July 2001. The target 
population was healthy, first-born infants with 
no underlying health conditions that might 
independently result in serious neurodevelop-
mental impairment. Therefore, women were 
considered eligible if they were primiparous 
with singleton pregnancies, had no underlying 
health conditions that might predispose them 
to have serious complications of pregnancy that 
might result in an at-risk infant, and ultimately 
delivered infants that were neither extremely 
preterm nor very low birth weight. (Berkowitz 
et al. 2003, 2004). Mother–infant pairs were 
recruited early in pregnancy (n = 479). In 
brief, subsequent to delivery, 75 women were 
excluded because of medical complications, 
very premature births (delivery before 32 com-
pleted weeks or birth weight < 1,500 g), deliv-
ery of an infant with a birth defect, inability to 
collect biologic specimens before birth, change 
of hospital or residence outside New York 
City, or refusal to continue to participate, leav-
ing 404 women–infant pairs in the final cohort 
(Berkowitz et al. 2004).
We administered a questionnaire to par-
ticipants during their third trimester of preg-
nancy to obtain information on environmental 
exposures, sociodemographic characteristics, 
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Ba c k g r o u n d: Prenatal exposure to organophosphate pesticides has been shown to negatively affect 
child neurobehavioral development. Paraoxonase 1 (PON1) is a key enzyme in the metabolism of 
organophosphates.
oB j e c t i v e: We examined the relationship between biomarkers of organophosphate exposure, 
PON1, and cognitive development at ages 12 and 24 months and 6–9 years.
Me t h o d s : The Mount Sinai Children’s Environmental Health Study enrolled a multiethnic prena-
tal population in New York City between 1998 and 2002 (n = 404). Third-trimester maternal urine 
samples were collected and analyzed for organophosphate metabolites (n = 360). Prenatal maternal 
blood was analyzed for PON1 activity and genotype. Children returned for neurodevelopment 
assessments ages 12 months (n = 200), 24 months (n = 276), and 6–9 (n = 169) years of age.
re s u l t s: Prenatal total dialkylphosphate metabolite level was associated with a decrement in 
mental development at 12 months among blacks and Hispanics. These associations appeared to be 
enhanced among children of mothers who carried the PON1 Q192R QR/RR genotype. In later 
childhood, increasing prenatal total dialkyl- and dimethylphosphate metabolites were associated 
with decrements in perceptual reasoning in the maternal PON1 Q192R QQ genotype, which 
imparts slow catalytic activity for chlorpyrifos oxon, with a monotonic trend consistent with greater 
decrements with increasing prenatal exposure.
co n c l u s i o n: Our findings suggest that prenatal exposure to organophosphates is negatively 
associated with cognitive development, particularly perceptual reasoning, with evidence of effects 
beginning at 12 months and continuing through early childhood. PON1 may be an important sus-
ceptibility factor for these deleterious effects.
key w o r d s : environmental exposures, IQ, mental development, organophosphates, pesticides. 
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obstetrical and medical history, and lifestyle 
factors. Women self-identified as white, white 
Hispanic, black, black Hispanic, or other. For 
the purpose of this analysis, white Hispanic 
and black Hispanics were jointly considered 
Hispanic. Maternal blood and urine samples 
were also obtained during a routine clinical 
visit, generally between 26 and 28 weeks of 
gestation. Delivery characteristics and birth 
outcomes, including birth weight, length, head 
circumference, gestational age and infant sex, 
were obtained from a computerized perinatal 
database within the Department of Obstetrics, 
Gynecology and Reproductive Science at 
Mount Sinai Hospital.
The Bayley Scales of Infant Development, 
2nd edition (BSID-II), was administered at 
the Mount Sinai Hospital at approximately 
12 (n = 200) and 24 months (n = 276). The 
BSID-II provides age-standardized norms 
of mental [Mental Development Index 
(MDI)] and psychomotor [Psychomotor 
Development Index (PDI)] development. The 
MDI rates the child’s cognitive ability in a 
number of areas, including memory, habitua-
tion, problem solving, early number concepts, 
generalization, classification, vocalizations, 
language, and social skills. The PDI rates the 
child’s fine and gross motor coordination. 
Scales are age standardized to a mean (± SD) 
of 100 ± 15 (Bayley 1993). Interviews and 
examinations were conducted in English or 
Spanish as required. Children were invited 
to return for Wechsler psychometric intelli-
gence tests between the ages of 6 and 9 years. 
Children that returned before 7 years of age 
were administered the Wechsler Preschool 
and Primary Scale of Intelligence, 3rd edi-
tion (WPPSI-III), which was administered 
in English or Spanish by one of four exam-
iners. Block Design, Information, Matrix 
Reasoning, Vocabulary, Picture Concepts, 
Symbol Search, Word Reasoning, and Coding 
subtests were completed. Composite Verbal, 
Performance, Processing speed, and Full-Scale 
IQ (FSIQ) scores were derived using age-stan-
dardized WPPSI-III norms. Children who 
returned between the ages of 7 and 9 years 
were administered the Wechsler Intelligence 
Scale for Children, 4th edition (WISC-IV) 
by one of four examiners. Children pro-
vided witnessed assent before the start of the 
assessment. Block Design, Similarities, Digit 
Span, Picture Concepts, Coding, Vocabulary, 
Letter-Number Sequence, Matrix Reasoning, 
Comprehension, and Symbol Search subtests 
were completed. Composite Verbal, Perceptual 
Reasoning, Working Memory, Processing 
Speed, and FSIQ scores were derived using 
age-standardized WISC-IV norms. Both the 
WPPSI-III and the WISC-IV were admin-
istered in a private room without the parent 
present. Mothers provided informed consent, 
and children ≥ 7 years of age provided verbal 
and witnessed assent. This study was approved 
by the Institutional Review Board of Mount 
Sinai School of Medicine.
Maternal urine samples were analyzed 
by the Centers for Disease Control and 
Prevention (CDC) for six dialkylphosphate 
metabolites in two batches. Laboratory and 
quality control methods have been reported 
previously (Barr et al. 2005; Bravo et al. 2004; 
Wolff et al. 2005). In some cases, individual 
dialkylphosphate metabolite levels were miss-
ing because of analytic interference. In these 
cases, missing dialkylphosphate metabolite lev-
els were imputed using regression analysis to 
predict the missing metabolite on the basis of 
the other nonmissing metabolites measured 
for that woman within the group of correlated 
metabolites, as has been previously described 
(Engel et al. 2007). Samples below the limit 
of detection (LOD) were defined as LOD/√
–
2. 
Diethyl- and dimethylphosphate metabo-
lites were summed (as micromoles per liter) 
to obtain total diethylphosphate metabolites 
(ΣDEP) and total dimethylphosphate metabo-
lites (ΣDMP), and total dialkylphosphate lev-
els (ΣDAP). Very dilute samples of urine with 
< 20 μg/dL creatinine (n = 26) were excluded 
from organophosphate metabolite analyses, 
in accordance with methods that have previ-
ously been applied for spot urine biomarker 
measures (Carrieri et al. 2001; Engel et al. 
2007; Eskenazi et al. 2004; Wolff et al. 2007). 
Overall, approximately 97%, 89%, and 90% 
of the cohort had detectable levels of ΣDAP, 
ΣDEP, and ΣDMP metabolites, respectively 
(Engel et al. 2007). A random subset of 
maternal peripheral blood samples from the 
entire cohort (n = 194), distributed roughly 
equally by maternal race/ethnicity (66 blacks, 
64 Hispanics, 64 whites, the number being 
dictated by budgetary considerations), was 
analyzed for polychlorinated biphenyls (PCBs) 
and 1,1´-dichloro-2,2´-bis(4-chlorophenyl)
ethylene (DDE). PCBs were defined as the 
sum of congeners 118, 153, 138, and 180 
(Wolff et al. 2005). Total lipids (grams per 
liter) were calculated by using cholesterol and 
triglycerides (Phillips et al. 1989) determined 
on the 174 plasma samples with sufficient vol-
ume. Distributions of biomarker levels have 
been previously reported (Engel et al. 2007; 
Wolff et al. 2007).
Plasma was separated from prenatal mater-
nal peripheral blood and cord blood at deliv-
ery and was used to measure PON1 activity by 
phenylacetate hydrolysis (Chen et al. 2005). 
Using maternal and child DNA, PON1 poly-
morphisms were also measured using clamp-
dependent and linking emulsion allele-specific 
polymerase chain reaction (Chen et al. 2005). 
We examined interactions between prenatal 
organophosphate exposure (dichotomized as 
above and below the median exposure) and 
tertiles of PON1 activity in maternal prenatal 
peripheral blood and child cord blood. We 
also examined interactions between prenatal 
organophosphate exposure and the maternal or 
child PON1 Q192R, –108C > T, and L55M 
polymorphisms. We closely examined interac-
tions if the type 3 F-test for the product-term 
in Proc GLM (either the class variable rep-
resenting biomarker tertiles × dichotomized 
genotypes or race/ethnicity, or the linear 
term for log10 organophosphate metabolites 
× dichotomized genotypes or race/ethnicity) 
was p < 0.20. The PON1 Q192R polymor-
phism in particular has been shown to have a 
strong functional consequence on the relative 
rate of hydrolysis of certain organophophate 
substrates (Li et al. 2000) and has been shown 
to affect the catalytic efficiency for chlorpyrifos 
but not diazinon (Richter et al. 2009).
Data were analyzed using SAS (version 9.1; 
SAS Institute Inc., Cary, NC). Generalized 
linear models were used to analyze the rela-
tionship between biomarker levels and MDI 
and PDI. In total, 200 children were adminis-
tered the BSID-II at approximately 12 months 
of age (mean ± SD, 13.1 ± 1.6 months). 
Children were excluded from analyses if their 
refusal to do a large proportion of the items 
on the examination influenced their overall 
score (12-month MDI, n = 1). Two children 
were excluded from the 12-month analysis 
because their parent reported a diagnosis of 
pervasive developmental disorder. We also 
excluded observations when urine creatinine 
was < 20 μg/dL in the maternal urine sample 
(n = 20). Of the remaining 177 eligible chil-
dren who completed 12-month exams, 174 
had organophosphate metabolites measured in 
prenatal urine.
At the 24-month BSID-II (mean ± SD, 
27.4 ± 4.5 months), 276 children completed 
the exam. Two were excluded from the 
24-month analysis because the parent reported 
a diagnosis of pervasive developmental disor-
der. Samples of urine < 20 μg/dL creatinine 
(n = 23) were also excluded. Of the remaining 
251 eligible observations, 247 had organo-
phosphate metabolites measured in prenatal 
urine. We could not compute the MDI scores 
for 10 additional children because their refus-
als were too extensive to accurately calculate 
scores; however, they were included in the 
PDI analyses because their scores were valid.
To maximize the sample size of our mod-
els, we conducted analyses that combined 
the FSIQ, Perceptual Reasoning, Verbal 
Comprehension, and Processing Speed com-
posite scores from children who came for at 
least one of the Wechsler psychometric intel-
ligence exams—in the text and tables we 
refer to this as the “combined population” 
(n = 169). For these analyses, we preferentially 
selected the WISC-IV composite scores and 
substituted the WPPSI-III composite scores if 
the child did not return for the later exam. We Engel et al.
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included an indicator variable to account for 
whether the scores derived from a WISC-IV 
or WPPSI-III exam. The convergent validity 
between the WISC-IV and WPPSI-III has 
been previously reported. Specifically, in psy-
chometric analyses, the correlation between 
WPPSI-III and WISC-IV FSIQ scores was 
0.89; WPPSI-III Verbal IQ and WISC-IV 
Verbal Comprehension, 0.83; and WPPSI-III 
Performance IQ and WISC-IV Perceptual 
Reasoning, 0.79 (Flanagan and Kaufman 
2004). In our study, among children who 
returned for both exams (n = 103), the cor-
relations between the composite scores on 
the WPPSI-III and WISC-IV were likewise 
very strong: FSIQ = 0.83, Verbal IQ/Verbal 
Comprehension = 0.84, and Performance IQ/
Perceptual Reasoning = 0.78. For all mod-
els, covariates were retained if their exclu-
sion caused more than a 10% change in 
the β-coefficient of the full model or if they 
improved the precision of the main effect 
estimate. The following covariates were con-
sidered as potential confounders or effect 
modifiers: maternal age, race/ethnicity, marital 
status, education, breast-feeding, child sex, 
alcohol, smoking, or drug use during preg-
nancy, maternal IQ (measured by the Peabody 
Picture Vocabulary test), Home Observation 
for Measurement of the Environment 
(HOME) score, season of urine collection, 
maternal PON1 activity or genotype, lan-
guage spoken in the home, and exact age at 
testing. Gestational age at delivery and birth 
weight were not evaluated for confounding 
because they are potentially causal intermedi-
ates (Moreno-Banda et al. 2009; Whyatt et al. 
2004; Wolff et al. 2007). All models were 
adjusted for examiner and urinary creatinine.
Results
The Mount Sinai Children’s Environmental 
Health Center enrolled a multiethnic inner-
city cohort, most of whom were black or 
Hispanic women (~ 80%) (Table 1). Most 
mothers in the cohort were < 25 years of age 
at enrollment. However, in some follow-up 
years, those who returned for follow-up assess-
ments tended to be older women, with a dis-
proportionately low fraction of women in 
the youngest category (< 20 years at enroll-
ment) being unreachable by any of our con-
tact methods. We found similar trends for 
education. Those returning for follow-up did 
not differ substantially from the originally 
enrolled cohort with respect to racial/ethnic 
composition. Importantly, we also found no 
meaningful differences with respect to breast-
feeding behaviors or alcohol use during preg-
nancy. In general, mothers who returned for 
follow-up assessments tended to have been 
older at enrollment and to have achieved a 
higher level of education. Allele frequencies for 
PON1 polymorphisms varied by race, as has 
been previously reported for our population 
(Chen et al. 2003). In the population of sub-
jects included in this analysis, the frequency 
of the A allele (resulting in Q amino acid) was 
74% among whites, 36% among blacks, and 
55% among Hispanics. The frequencies of the 
–108T allele and 55L alleles were also differen-
tial by race. For a detailed description of allele 
frequencies and metabolite concentrations 
according to race, see Supplemental Material, 
Table 1 (doi:10.1289/ehp.1003183).
At the 12-month BSID-II exam, the esti-
mated effect of organophosphate metabolites 
on the MDI was strongly heterogeneous by 
race/ethnicity for the ΣDAP and ΣDMP 
metabolites (Table 2). Among nonwhites, 
increasing ΣDAP and ΣDMP tertiles of expo-
sure were associated with a decrease in the 
MDI [log10 ΣDAP: β = –3.29; 95% confi-
dence interval (CI), –5.88 to –0.70]. However, 
among whites, the reverse pattern emerged, 
with higher exposure associating with better 
MDI scores (log10 ΣDAP: β = 4.77; 95% CI, 
0.69–8.86). We found similar trends in the 
effect estimates when we stratified by housing 
type (public vs. private) rather than race/eth-
nicity. We found no heterogeneity in ΣDEP 
effect estimates according to race/ethnicity, 
and overall, ΣDEP metabolites were not asso-
ciated with the 12-month BSID-II MDI. We 
found no relationship between organophos-
phate metabolites and the PDI at 12 months 
overall, and no interaction with race/ethnicity 
for any of the metabolite groups (Table 2). 
At the 24-month BSID-II, effect estimates 
were not heterogeneous by race/ethnicity (data 
not shown). Consistent with the 12-month 
assessment, prenatal maternal ΣDAP metabo-
lite level was inversely associated with the 
24-month MDI (β = –2.08; 95% CI, –4.60 
to 0.44) in multivariate adjusted models, 
although the effect estimates were attenu-
ated relative to the 12-month estimates and 
measured with comparable precision [see 
Supplemental Material, Table 2 (doi:10.1289/
ehp.1003183)]. The metabolites were not 
associated with 24-month PDI.
Because of the strong interaction between 
race/ethnicity and organophosphate metabo-
lites on the BSID-II MDI at 12 months, we 
examined the interaction between the PON1 
polymorphisms and ΣDAP and ΣDMP 
metabolites within strata of race/ethnicity; 
however, the white population was too small 
to further subdivide by genotype. Therefore, 
we restricted this analysis to only the black 
Table 1. Characteristics of the Mount Sinai Children’s Environmental Health Study, Mount Sinai Medical 
Center, 1998–2002 [n (%)].
Original 
enrolled cohort  
(n = 404)
Follow-up
Characteristic
12 months  
(n = 200)
24 months  
(n = 276)
6–9 years  
(n = 169)
Maternal age at delivery (years  )
< 20 142 (35.2) 57 (28.5) 96 (34.8) 54 (31.9)
20–24 132 (32.7) 56 (28.0) 83 (30.1) 56 (33.1)
25–29 44 (10.9) 30 (15.0) 34 (12.3) 25 (14.8)
30–34 64 (15.8) 39 (19.5) 43 (15.6) 19 (11.2)
≥ 35 22 (5.4) 18 (9.0) 20 (7.2) 15 (8.9)
Race/ethnicity
White 86 (21.29) 57 (28.5) 63 (22.8) 31 (18.3)
Black 112 (27.72) 52 (26.0) 74 (26.8) 47 (27.8)
Hispanic 200 (49.50) 89 (44.5) 136 (49.3) 88 (52.1)
Other 6 (1.49) 2 (1.0) 3 (1.1) 3 (1.8)
Marital status
Married 117 (29.0) 71 (35.5) 81 (29.4) 38 (22.5)
Living with baby’s father 98 (24.3) 41 (20.5) 62 (22.5) 40 (23.7)
Single 189 (46.8) 88 (44.0) 133 (48.2) 91 (53.9)
Education
< High school 118 (29.4) 50 (25.0) 78 (28.3) 46 (27.2)
High school graduate 83 (20.7) 35 (17.5) 55 (19.9) 36 (21.3)
Some college 103 (25.6) 49 (24.5) 70 (25.4) 51 (30.2)
≥ Bachelor’s degree 98 (24.4) 66 (33.0) 73 (26.5) 36 (21.3)
Alcohol use during pregnancy 59 (14.0) 31 (16.0) 36 (13.4) 28 (16.9)
Duration of breast-feeding (months)
< 1 140 (42.2) 74 (37.0) 122 (44.2) 73 (43.5)
1–3 71 (21.4) 45 (22.5) 56 (20.3) 36 (21.4)
≥ 4 121 (36.5) 81 (40.5) 98 (35.5) 59 (35.1)
Any organophosphate biomarker level 383 (94.8) 190 (95.0) 267 (96.7) 165 (99.0)
Maternal PON1 Q192R
QQ 120 (30.9) 63 (33.3) 78 (30.2) 46 (28.2)
QR 174 (44.7) 83 (43.9) 119 (46.1) 78 (47.9)
RR 95 (24.4) 43 (22.8) 61 (23.6) 39 (23.9)
Maternal paraoxonase enzyme activity (units/mL)
2,964–9,576 (tertile 1) 130 (33.9) 69 (37.5) 91 (35.7) 57 (34.8)
9,700–11,660 (tertile 2) 123 (32.1) 51 (27.7) 81 (31.8) 43 (26.2)
11,665–20,000 (tertile 3) 130 (33.9) 64 (34.8) 83 (32.6) 64 (39.0)Prenatal pesticides and cognitive development
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or Hispanic population. Among blacks and 
Hispanics, the effects of ΣDAP, ΣDEP, and 
ΣDMP were strongly differential according to 
PON1 Q192R genotype at 12 months but not 
24 months. At 12 months, children of mothers 
with the PON1 192 QR/RR genotype experi-
enced approximately a 5-point decline on the 
MDI with each log10 unit increase in ΣDAP or 
ΣDMP biomarker level which was monotonic 
across tertiles [see Supplemental Material, 
Figure (doi:10.1289/ehp.1003183)], and a 
2-point decline in MDI for each log10 unit 
increase in ΣDEP biomarker level (Table 3). 
There was essentially no effect among children 
of mothers with the QQ genotype. Although 
in some instances the point estimates among 
the QQ group were quite elevated in a posi-
tive direction, they were always estimated with 
imprecision and did not follow a monotonic 
pattern. Results were consistent when we 
stratified by black and Hispanic ancestry (see 
Supplemental Material, Table 3), although 
the sample size was quite small. We found 
no interaction between the PON1 Q192R 
polymorphism and organophosphate metabo-
lite level on the MDI at 24 months. We also 
found no interactions (p ≥ 0.20) between 
organophosphate metabolites and the L55M 
or –108C > T polymorphisms, or with enzyme 
activity, on neurodevelopment at any age. 
Results were similar when we estimated associ-
ations according to the child’s PON1 Q192R 
genotype instead of the mother’s genotype, 
but child genotype was available for only 57% 
of the population because cord blood was col-
lected for only a subset. Therefore, we report 
only the maternal gene–organophosphate 
interactions.
Increasing ΣDEP metabolite levels were 
associated with slight decrements in FSIQ 
(log10 β = –2.89; 95% CI, –6.15 to 0.36) 
and Perceptual Reasoning (log10 β = –3.51; 
95% CI, –7.31 to 0.30) on the combined 
psychometric exams, and also with Working 
Memory (log10 β = –3.48; 95% CI, –7.29 
to 0.34) on the 7–9 year WISC-IV examina-
tion (Table 4), although the estimated effects 
were relatively modest and imprecise. These 
Table 2. Prenatal organophosphate biomarker levels and 12-month BSID-II MDI in the Mount Sinai Children’s Environmental Health Study.
Organophosphate biomarker
Combined race/ethnicitya (n = 149) Black/Hispanic subjectsb (n = 111) White subjectsb (n = 38) Interaction 
p-value Adjusted mean 95% CI Adjusted mean 95% CI Adjusted mean 95% CI
MDI
ΣDAP
T3 96.1 93.1 to 99.0 91.5 88.3 to 94.7 103.7 98.5 to 108.8 < 0.001
T2 95.8 92.5 to 99.1 94.4 91.2 to 97.5 95.9 90.6 to 101.3
T1 97.0 93.7 to 100.3 96.2 92.9 to 99.4 92.0 85.4 to 98.7
Log10 β –1.00 –3.28 to 1.28 –3.29 –5.88 to –0.70 4.77 0.69 to 8.86 0.001
ΣDEP
T3 97.5 94.3 to 100.6 95.2 91.9 to 98.6 100.6 94.6 to 106.5 0.82
T2 95.4 92.3 to 98.6 93.8 90.4 to 97.1 96.8 90.8 to 102.9
T1 95.9 92.9 to 98.9 94.3 90.9 to 97.6 97.3 91.8 to 102.7
Log10 β 0.03 –2.23 to 2.29 –0.33 –3.00 to 2.35 0.86 –3.16 to 4.87 0.62
ΣDMP
T3 96.1 93.4 to 99.0 92.1 89.0 to 95.2 103.3 97.9 to 108.7 < 0.01
T2 96.1 92.9 to 99.3 94.2 91.0 to 97.4 97.2 91.1 to 102.6
T1 96.8 93.5 to 100.0 96.3 93.0 to 99.5 92.2 85.6 to 98.7
Log10 β –1.12 –3.14 to 0.89 –3.35 –5.64 to –1.06 4.45 0.82 to 8.08 < 0.001
PDI
ΣDAP
T3 92.5 88.5 to 96.6 94.2 89.5 to 98.9 90.8 83.3 to 98.2 0.65
T2 96.6 92.1 to 101.1 97.5 93.0 to 102.1 97.0 89.2 to 104.7
T1 95.3 90.9 to 99.8 97.7 93.1 to 102.4 90.0 80.5 to 99.6
Log10 β –0.52 –3.66 to 2.62 –1.52 –5.21 to 2.16 2.07 –3.83 to 7.96 0.31
ΣDEP
T3 93.6 89.3 to 98.0 95.6 91.0 to 100.2 91.7 83.5 to 99.9 0.25
T2 94.5 90.1 to 98.9 95.9 91.2 to 100.6 94.4 86.0 to 102.7
T1 95.3 91.2 to 99.5 97.7 93.1 to 102.4 92.1 84.6 to 99.6
Log10 β –0.20 –3.28 to 2.87 –0.48 –4.11 to 3.16 0.46 –5.12 to 6.03 0.78
ΣDMP
T3 94.5 90.6 to 98.5 96.4 92.0 to 100.8 92.5 84.9 to 100.2 0.83
T2 93.7 89.3 to 98.0 94.5 90.1 to 99.0 94.4 86.7 to 102.1
T1 95.1 90.7 to 99.5 97.8 93.2 to 102.4 89.5 80.2 to 98.8
Log10 β –0.92 –3.68 to 1.85 –1.81 –5.07 to 1.45 1.36 –3.83 to 6.56 0.31
T, tertile. 
aGeneral linear model adjusted for race/ethnicity, maternal age at enrollment, child sex, examiner, maternal PON1 enzyme activity, season of urine collection, laboratory batch, HOME 
score, alcohol consumption during pregnancy, and urinary creatinine. bGeneral linear model adjusted for maternal age at enrollment, child sex, examiner, maternal PON1 enzyme 
  activity, season of urine collection, laboratory batch, HOME score, alcohol consumption during pregnancy, and urinary creatinine and including a biomarker–race interaction term. 
Table 3. PON1 Q192R interaction with ΣDAP, ΣDEP, and ΣDMP levels on the BSID-II MDI in the Mount Sinai Children’s Environmental Health Study.
12-month BSID-II: black/Hispanic subjects (n = 110)a 24-month BSID-II: total population (n = 197)
PON1 192 QQ  
(slow; n = 28)
PON1 192 QR/RR 
(fast;b n = 82) Interaction 
p-value
PON1 192 QQ 
(slow; n = 57)
PON1 192 QR/RR 
(fast; n = 140) Interaction 
p-value Biomarker log10 β 95% CI log10 β 95% CI log10 β 95% CI log10 β 95% CI
ΣDAP 5.72 –0.48 to 11.92 –4.94 –7.81 to –2.07 < 0.01 –1.04 –6.06 to 3.99 –1.27 –4.40 to 1.84 0.93
ΣDEP 3.69 –0.97 to 8.36 –1.95 –5.36 to 1.47 0.06 –0.55 –4.79 to 3.70 –0.15 –3.51 to 3.21 0.88
ΣDMP 2.76 –2.44 to 7.97 –4.47 –7.05 to –1.89 0.02 0.12 –4.17 to 4.42 –0.48 –3.27 to 2.30 0.81
Data are for a general linear model adjusted for maternal age at enrollment, child sex, examiner, HOME score, alcohol consumption during pregnancy, laboratory batch, season of 
urine collection, urinary creatinine, and including a biomarker–PON1 Q192R genotype interaction. The 24-month model was additionally adjusted for maternal race/ethnicity.
aOne subject identified mixed ethnicity. bIn this category, seven were black and the remainder Hispanic.Engel et al.
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associations were not heterogeneous by race/
ethnicity. However, for the combined popu-
lation, we again found effect heterogeneity 
according to the PON1 Q192R polymor-
phism for the associations between ΣDAP 
and ΣDMP biomarkers and perceptual rea-
soning domain. In contrast to the 12-month 
BSID-II MDI, children of mothers with the 
slow-catalytic-activity genotype (QQ) experi-
enced a substantial decrement in the overall 
perceptual reasoning score with each log10 
increment increase in exposure, whereas we 
found no effect of ΣDAP and ΣDMP bio-
markers on the perceptual reasoning score 
of children with mothers who carried the 
QR/RR genotypes (Table 5). Comparing bio-
marker tertiles according to genotype, increas-
ing tertiles of ΣDAP, ΣDEP, and ΣDMP 
among the children of mothers with the 
PON1 192QQ genotype were generally asso-
ciated with monotonically declining adjusted 
means in FSIQ and perceptual reasoning, 
whereas we found no consistent pattern in 
the QR/RR group (Figure 1). For perceptual 
reasoning, the first- versus third-tertile con-
trasts for ΣDAP and ΣDMP were statistically 
significant (p < 0.05).
Maternal third-trimester blood PCB 
concentration was inversely associated with 
mental development at 12 months (loge β = 
–7.18; 95% CI, –14.47 to 0.11) but not at 
24 months (loge β = 1.60; 95% CI, –6.57 
to 9.77) and was not associated with IQ [see 
Supplemental Material, Table 4 (doi:10.1289/
ehp.1003183)]. However, although the effect 
estimates for PCBs were sometimes quite 
large, they were also measured with extreme 
imprecision, as indicated by the very large CIs. 
Maternal third-trimester blood DDE was not 
associated with any of the outcome measures.
Discussion
We report an association between prenatal 
increasing ΣDAP and ΣDMP urinary metabo-
lite concentrations and poorer scores on the 
BSID-II MDI at 12 months among blacks 
and Hispanics. At some ages, these associations 
were modified by maternal PON1 Q192R 
genotype, although the interaction effects 
across exam years were not entirely consistent. 
For the 12-month exam, the strongest negative 
associations with organophosphate exposure 
was found in the QR/RR group, whereas for 
the psychometric exams the strongest negative 
associations were found in the QQ group. An 
explanation for a switch in the enhanced-risk 
genotype is not readily apparent; however, 
PON1 is a complex gene involved in multiple 
physiological processes, including organophos-
phate metabolism but also lipid peroxidation 
and oxidative stress (Li et al. 2003), which 
may impact neurodevelopment independently 
(Eskenazi et al. 2010) and/or jointly with 
organophosphate exposure. 
Heterogeneity according to maternal race/
ethnicity may indicate differences in exposure 
sources rather than any underlying susceptibil-
ity. As previously described, overall, 46.4% 
of our mothers reported that pesticides were 
applied in their home either by themselves or 
by a family member during their pregnancy, 
although there was a profound racial dispar-
ity in this behavior (Berkowitz et al. 2003). 
Among the women who returned for the 
12-month BSID-II exam in the present study, 
70.5% of the blacks and Hispanics reported 
buying pesticides, applying pesticides, or fumi-
gating their house during their pregnancy, 
compared with only 31.6% of the whites, and 
yet we did not detect significant differences in 
their exposure distributions [see Supplemental 
Material, Table 1 (doi:10.1289/ehp.1003183)]. 
In our population, race/ethnicity was strongly 
associated with whether a subject lived in pub-
lic or private housing. And indeed, we found 
similar trends in the effect estimates when we 
stratified by housing type (public vs. private) 
rather than race/ethnicity, although the mag-
nitude of the interaction was not as strong. 
This indicates that whites, or people living in 
private or owner-occupied housing, may have 
experienced a different source of exposure to 
pesticides or their metabolites that contributed 
substantially to their urinary concentrations; 
one possibility is that pesticide residues from 
fresh fruit and vegetable consumption account 
for a large fraction of the urinary metabo-
lite levels among whites. Unfortunately, this 
presents serious complications for exposure 
reconstruction using urinary metabolites. A 
recent examination of dialkylphosphate resi-
dues on fruits and vegetables found that more 
than half of the samples tested contained more 
preformed dialkylphosphate residues than par-
ent organophosphate pesticides (Zhang et al. 
2008). These dialkylphosphate residues were 
produced by abiotic hydrolysis, photolysis, or 
plant metabolism (Zhang et al. 2008). Direct 
intake of the metabolite (i.e., pesticide residue) 
without the active oxon, rather than the parent 
pesticide, does not inhibit cholinesterase activ-
ity. Thus, for subjects for whom the primary 
Table 4. Prenatal organophosphate biomarker levels and psychometric intelligence at 6–9 years in the 
Mount Sinai Children’s Environmental Health Study.
Log10 ΣDAP Log10 ΣDEP Log10 ΣDMP
n β 95% CI n β 95% CI n β 95% CI
Combined populations (6–9 years)
FSIQ 140 –1.39 –4.54 to 1.77 140 –2.89 –6.15 to 0.36 142 –0.46 –3.17 to 2.26
Perceptual Reasoning –2.36 –6.04 to 1.31 –3.51 –7.31 to 0.30 –1.15 –4.31 to 2.02
Verbal Comprehension –0.42 –3.45 to 2.62 –1.20 –4.35 to 1.96 –0.05 –2.64 to 2.54
WISC-IV (7–9 years)
FSIQ 114 –1.10 –5.01 to 2.81 114 –3.15 –7.19 to 0.89 115 –0.39 –3.64 to 2.86
Perceptual Reasoning –2.39 –6.97 to 2.19 –4.37 –9.10 to 0.36 –1.24 –5.05 to 2.57
Verbal Comprehension 0.56 –3.11 to 4.23 –0.08 –3.91 to 3.76 0.39 –2.65 to 3.42
Processing Speed –1.05 –5.57 to 3.46 –2.11 –6.81 to 2.59 –0.79 –4.52 to 2.94
Working Memory –0.53 –4.24 to 3.18 –3.48 –7.29 to 0.34 0.29 –2.81 to 3.38
WPPSI-III (6 years)
FSIQ 96 –1.14 –4.55 to 2.28 96 –1.40 –5.27 to 2.47 98 –0.56 –3.68 to 2.56
Perceptual Reasoning –2.07 –5.66 to 1.52 –1.59 –5.68 to 2.50 –1.46 –4.74 to 1.83
Verbal Comprehension –1.16 –4.59 to 2.27 –2.27 –6.14 to 1.60 –0.52 –3.67 to 2.62
Processing Speed –1.22 –5.12 to 2.67 –1.85 –6.25 to 2.56 –0.84 –4.35 to 2.67
Data are for a generalized linear models adjusted for sex, race/ethnicity, maternal education, language in the home, 
maternal PON1 enzymatic activity, alcohol use in pregnancy, batch season of urine collection, and urinary creatinine. 
Combined population models additionally adjusted for whether the score came from the WISC-IV or WPPSI-III instrument.
Table 5. Joint prenatal organophosphate biomarker and PON1 Q192R effect on combined IQ domains at 
6–9 years in the Mount Sinai Children’s Environmental Health Study.
PON1 192 QR/RR 
(fast; n = 101)
PON1 192 QQ 
(slow; n = 39) Interaction 
p-value β 95% CI β 95% CI
FSIQ
Log10 ΣDAP –0.66 –4.33 to 3.00 –2.33 –8.40 to 3.74 0.64
Log10 ΣDEP –2.32 –6.49 to 1.86 –3.13 –8.21 to 1.96 0.80
Log10 ΣDMP 0.28 –2.89 to 3.44 –1.79 –6.83 to 3.25 0.49
Perceptual Reasoning
Log10 ΣDAP –0.56 –4.80 to 3.68 –7.52 –14.53 to –0.51 0.09
Log10 ΣDEP –3.24 –8.11 to 1.62 –4.80 –10.73 to 1.13 0.68
Log10 ΣDMP 0.71 –2.96 to 4.38 –6.15 –11.99 to –0.31 0.05
Verbal Comprehension
Log10 ΣDAP –0.33 –3.87 to 3.20 0.73 –5.12 to 6.59 0.76
Log10 ΣDEP –0.45 –4.51 to 3.60 –1.20 –6.13 to 3.74 0.81
Log10 ΣDMP 0.12 –2.93 to 3.16 0.24 –4.60 to 5.09 0.97
Generalized linear models adjusted for sex, race/ethnicity, maternal education, language in the home, alcohol use in 
pregnancy, batch season of urine collection, urinary creatinine, and an indicator variable to designate the WISC-IV or 
WPPSI-III instrument.Prenatal pesticides and cognitive development
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source of pesticide exposure is fresh fruit and 
vegetable consumption, use of urinary metabo-
lite concentrations as an indication of parent 
compound exposure may result in significant 
misclassification of exposure.
Prenatal ΣDEP urinary metabolite concen-
trations were associated with slight decrements 
in FSIQ, Perceptual Reasoning, and Working 
Memory between the ages of 6 and 9 years. 
Furthermore, among children of QQ mothers, 
ΣDAP and ΣDMP urinary metabolite concen-
trations were associated with poorer scores on 
Perceptual Reasoning and FSIQ in a mono-
tonically decreasing manner. In both cases, 
we observed stronger Q192R interactions for 
ΣDAP and ΣDMP urinary metabolites, rather 
than ΣDEP metabolites. The reasons for this 
are unclear. PON1 Q192R exhibits substrate 
specificity (Richter et al. 2009), but our stron-
gest interactions were for dimethylphosphates, 
not diethylphosphates (into which chlorpyrifos 
and diazinon both metabolize). An alternative 
explanation is that our dimethylphosphate 
metabolite concentrations were simply higher 
(Engel et al. 2007), indicating more available 
substrate. Unfortunately, the relevant parent 
compounds cannot be deduced on the basis of 
nonspecific urinary dialkylphosphates; how-
ever, one well-publicized source of dimethyl-
phosphate exposure during the period of 
enrollment was malathion spraying for mos-
quitoes carrying West Nile virus (Nash et al. 
2001; O’Sullivan et al. 2005). Interestingly, 
PON1 status may indirectly influence methyl 
organophosphate metabolism when multi-
ple organophosphate exposures are involved 
(Jansen et al. 2009).
The estimated effects we report for 
the BSID-II MDI are in line with what has 
recently been reported in the CHAMACOS 
(Center for the Health Assessment of Mothers 
and Children of Salinas) study (Eskenazi et al. 
2010), a similarly designed prospective birth 
cohort that enrolled members of an agricultural 
community in the Salinas Valley of California. 
Eskenazi et al. (2010) reported evidence of 
negative effects of ΣDAPs on the MDI, but 
not the PDI, and particularly among children 
with the QQ genotype, although there did not 
appear to be strong effect heterogeneity in the 
dialkylphosphate–MDI relationship according 
to PON genotype, and in some circumstances 
the RR and QQ effect estimates were extremely 
similar. Although we report interactions with 
maternal PON1 Q192R genotype, we found 
very similar interactions and effect estimates for 
child genotype in our cohort (data not shown). 
In no cases did we detect effect heterogeneity 
according to PON1 enzyme activity, perhaps 
because genotype is a more stable, long-term 
predictor of metabolism potential. Reconciling 
estimated effects across studies can be compli-
cated when only nonspecific urinary metabo-
lites are measured because these metabolites 
can derive from multiple parent compounds 
(CDC 2010) that may vary in the degree to 
which they interact with the Q192R genotype 
and influence neurodevelopment.
Ours was a multiethnic study popula-
tion recruited at an inner-city tertiary care 
hospital that serves a lower-income minor-
ity population. Thus, attrition resulting from 
the challenges of maintaining contact with 
this population may have affected our study 
findings. Misclassification of parent com-
pound exposure according to exposure route is 
another significant limitation of our study and 
other studies relying on urinary dialkylphos-
phate biomarkers and may explain the hetero-
geneity in effects observed according to race/
ethnicity in our population. It may further 
complicate the comparison of exposure effects 
across studies where heterogeneity exists in 
exposure sources. Additionally, we measured 
dialkylphosphate biomarkers at one time dur-
ing pregnancy, approximately the early third 
trimester. Although we accounted for seasonal 
variation in exposure levels in our model, other 
time-related variability may result in additional 
misclassification of exposure.
Finally, residual confounding by unmeas-
ured covariates, including postnatal exposure, 
should be considered when evaluating our 
results. Our study enrollment and evaluation 
periods overlapped with important regulatory 
changes in residential use of chlorpyrifos and 
diazinon, which occurred approximately mid-
way through our study. Therefore, childhood 
exposure to these compounds may vary sub-
stantially pre- versus postban, although we did 
not observe any significant interaction with 
study year (data not shown). However, these 
changes may explain the inconsistency between 
our 12- and 24-month BSID-II results. The 
0- to 12-month exposure window may include 
less hand-to-mouth childhood exposure (from 
crawling exposure to house dust, and/or fresh 
fruit and vegetable consumption) than in the 
12- to 24-month window; thus, more child-
hood exposure in the 12- to 24-month window 
may modify the effect of prenatal exposure. 
Nonetheless, it is likely, overall, that childhood 
exposure to chlorpyrifos and diazinon was 
lower postban (Williams et al. 2008).
Conclusion
We found that prenatal maternal urinary 
dialkyl  phosphate metabolite concentrations 
were negatively associated with aspects of 
neuro  development at 12 and 24 months, and 
also at 6–9 years of age, in an urban, inner-city 
population. At the later ages, the evidence was 
strongest among the children of mothers with 
the PON1 192QQ genotype, which was pres-
ent in approximately 30% of our population 
overall, although that varies according to racial 
ancestry. This important potential source of 
effect heterogeneity should be considered in 
future studies of organophosphate exposure.
Figure 1. Multivariate adjusted mean estimates and 95% CIs according to tertiles (T) of exposure and PON1 Q192R genotype. Among the children of mothers with 
the PON1 192QQ genotype (triangles), increasing tertile of ΣDAP, ΣDEP, and ΣDMP exposure was generally associated with a monotonic decline in the combined 
WISC-IV/WPPSI-III FSIQ and Perceptual Reasoning domains, adjusted for sex, race/ethnicity, maternal education, language in the home, alcohol use in preg-
nancy, batch and season of urine collection, urinary creatinine, and an indicator variable to designate the WISC-IV or WPPSI-III instrument. We found no consis-
tent patterns in the QR/RR genotype group (squares). There was considerable imprecision in all estimates. The first- versus third-tertile contrasts for Perceptual 
Reasoning were significantly different at p < 0.05 for ΣDAP and ΣDMP. 
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co r r e c t i o n
Estimated betas and confidence intervals 
for the 12 and 24 month MDI in Table 3 
and Supplemental Material Table 3 were 
inadvertently attributed to the incorrect 
genotype in the manuscript originally pub-
lished online. Estimated betas and con-
fidence intervals previously ascribed to 
the QQ genotype instead belonged to the 
QR/RR genotype, and vice versa. Therefore 
the negative effects of exposure on MDI at 
12 months were actually found among the 
QR/RR group, with essentially no effect 
found in the slow-catalytic activity QQ 
genotype. A revised Supplemental Material 
file has been placed online.
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